Cargando…

Safety of Omalizumab During Pregnancy and Breast-Feeding With Assessment of Placental Transfer: A Case Report

Detalles Bibliográficos
Autores principales:	Majou, Doriane, Moreira, Baptiste, Martin, Clémence, Chhun, Stéphanie, Treluyer, Jean-Marc, Tsatsaris, Vassilis, Chouchana, Laurent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984957/ https://www.ncbi.nlm.nih.gov/pubmed/33733644 http://dx.doi.org/10.4168/aair.2021.13.3.515

Ejemplares similares

Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019
por: Louchet, Margaux, et al.
Publicado: (2020)

Highly Significant Association between Two Common Single Nucleotide Polymorphisms in CORIN Gene and Preeclampsia in Caucasian Women
por: Stepanian, Alain, et al.
Publicado: (2014)

The impact of maternal‐fetal omalizumab transfer on peanut‐specific responses in an ex vivo placental perfusion model
por: Kothari, Akash, et al.
Publicado: (2022)

Functional Role of P-Glycoprotein and Binding Protein Effect on the Placental Transfer of Lopinavir/Ritonavir in the Ex Vivo Human Perfusion Model
por: Ceccaldi, Pierre-Francois, et al.
Publicado: (2009)

Pattern of secretion of pregnancy-associated plasma protein-A (PAPP-A) during pregnancies complicated by fetal aneuploidy, in vivo and in vitro
por: Leguy, Marie Clémence, et al.
Publicado: (2014)

Kidney disorders as serious adverse drug reactions of remdesivir in coronavirus disease 2019: a retrospective case–noncase study
por: Chouchana, Laurent, et al.
Publicado: (2021)

Balancing the reactogenicity of the ChAdOx1 nCov-19 vaccine against COVID-19 and the urgent need of a large immunization in healthcare workers
por: Chouchana, Laurent, et al.
Publicado: (2022)

Immune thrombocytopenia following ChAdOx1 vaccine and positive rechallenge with BNT162b2 vaccine: A case report with pharmacovigilance analysis()
por: Murarasu, Anne, et al.
Publicado: (2023)

Risque de vascularites systémiques après une vaccination anti-SARS-CoV-2 à base d’ARN : une étude de pharmacovigilance
por: Mettler, C., et al.
Publicado: (2022)

IgG Placental Transfer in Healthy and Pathological Pregnancies
por: Palmeira, Patricia, et al.
Publicado: (2012)

Efficacy and safety of omalizumab therapy in urticaria vasculitis
por: Petrelli, Fiorella, et al.
Publicado: (2022)

Megacystis in the first trimester of pregnancy: Prognostic factors and perinatal outcomes
por: Lesieur, Emmanuelle, et al.
Publicado: (2021)

Case Report: Omalizumab for Chronic Spontaneous Urticaria in Pregnancy
por: Liao, Shuang-Lu, et al.
Publicado: (2021)

Placental Growth Factor for the Prediction of Adverse Outcomes in Patients with Suspected Preeclampsia or Intrauterine Growth Restriction
por: Sibiude, Jeanne, et al.
Publicado: (2012)

Diagnostic value of fetal autopsy after early termination of pregnancy for fetal anomalies
por: Peyronnet, Violaine, et al.
Publicado: (2022)

HOMOGRAFT IMMUNITY IN PREGNANCY : THE PLACENTAL TRANSFER OF CYTOTOXIC ANTIBODY IN RABBITS
por: Lanman, Jonathan T., et al.
Publicado: (1965)

Placental Abruption Revealed by Hemoperitoneum: A Case Report
por: Bertholdt, C., et al.
Publicado: (2016)

Omalizumab's efficacy and safety against chronic spontaneous urticaria
por: Özdemir, Öner
Publicado: (2023)

Omalizumab in Children
por: Licari, Amelia, et al.
Publicado: (2014)

Association of Antihypertensive Agents with the Risk of In-Hospital Death in Patients with Covid-19
por: Chouchana, Laurent, et al.
Publicado: (2021)

Correction to: Association of Antihypertensive Agents with the Risk of In-Hospital Death in Patients with Covid-19
por: Chouchana, Laurent, et al.
Publicado: (2021)

Local anesthetics systemic toxicity in children: analysis of the French pharmacovigilance database
por: Schweitzer-Chaput, Arnaud, et al.
Publicado: (2023)

Risk Factors of Superimposed Preeclampsia in Women with Essential Chronic Hypertension Treated before Pregnancy
por: Lecarpentier, Edouard, et al.
Publicado: (2013)

Prevalence of hypertensive disorders during pregnancy in France (2010‐2018): The Nationwide CONCEPTION Study
por: Olié, Valérie, et al.
Publicado: (2021)

Safety Evaluation of an Expedited Omalizumab Home Self-Administration Pathway
por: Hussain, Zobia, et al.
Publicado: (2021)

Safety and effectiveness of omalizumab for the treatment of chronic urticaria in pediatric patients
por: Dekkers, Coco, et al.
Publicado: (2021)

Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange
por: Pennington, Luke F., et al.
Publicado: (2016)

Doxazosin treatment of phaeochromocytoma during pregnancy: placental transfer and disposition in breast milk
por: Versmissen, Jorie, et al.
Publicado: (2016)

Management of sulfonylurea‐treated monogenic diabetes in pregnancy: implications of placental glibenclamide transfer
por: Shepherd, M., et al.
Publicado: (2017)

Placental Barrier on Cadmium Transfer from Mother to Fetus in Related to Pregnancy Complications
por: Dong, Xudong, et al.
Publicado: (2023)

Placental transfer of pesticides studied in human placental perfusion
por: Mathiesen, Line, et al.
Publicado: (2020)

Omalizumab—A Review
por: Godse, Kiran, et al.
Publicado: (2015)

Dysregulation of placental vascular development- a mechanism for adverse pregnancy outcomes in placental malaria
por: Ozarslan, Nida, et al.
Publicado: (2021)

Lack of consensus in the choice of termination of pregnancy for Turner syndrome in France
por: Hermann, Monika, et al.
Publicado: (2019)

Country-based report: the safety of omalizumab treatment in pregnant patients with asthma
por: GEMİCİOĞLU, Bilun, et al.
Publicado: (2021)

Low Rate of Pandemic A/H1N1 2009 Influenza Infection and Lack of Severe Complication of Vaccination in Pregnant Women: A Prospective Cohort Study
por: Launay, Odile, et al.
Publicado: (2012)

Modulations of human placental transfer of lopinavir, ritonavir and enfuvirtide
por: Ceccaldi, Pierre-François, et al.
Publicado: (2010)

Good outcomes of pregnancy in two cases of women treated with omalizumab due to the severe asthma
por: Kuprys-Lipinska, Izabela, et al.
Publicado: (2013)

Severe asthma and the omalizumab option
por: Miller, Christopher WT, et al.
Publicado: (2008)

Omalizumab treatment in brittle asthma
por: Skiepko, Roman, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ojb80pcbfkn1klbft7i8h11age